Replies to post #19802 on ViaDerma Inc (VDRM)

[whatarush12]

MJ licensing will be HUGE.
I expect a PR this week or next that will send us over 10 cents

https://marijuanaindex.com/sector/biotechnology/ Check out those listed as #31 on this list!!!!!!!

32 Companies
Name Symbol Price Change % Volume Market Cap Exchange
GW Pharmaceuticals Plc GWPH 117.930 1.39 % 281,219 $2.97b NSD
Insys Therapeutics Inc. INSY 11.030 6.47 % 1,050,617 $793.69m NSD
Axim Biotechnologies Inc AXIM 13.350 11.16 % 63,248 $687.43m OTCQB
Zynerba Pharmaceuticals Inc. ZYNE 24.780 12.18 % 1,709,777 $327.46m NSD
Cannabics Pharmaceuticals Inc CNBX 2.570 -6.20 % 1,082,513 $293.29m OTCQB
Cure Pharmaceutical Holding Corp CURR 6.800 -4.90 % 3,655 $169.89m OTCQB
Cannabis Science Inc CBIS 0.071 -5.07 % 33,704,736 $164.64m OTCPK
22nd Century Group Inc. XXII 1.330 -1.48 % 838,617 $122.44m NYSE MKT
OWC Pharmaceutical Research Corp OWCP 0.720 -18.18 % 5,536,826 $97.42m OTCQB
InMed Pharmaceuticals Inc IN:CNX 0.880 15.79 % 2,474,652 $95.34m CSE
PharmaCyte Biotech Inc PMCB 0.097 2.55 % 1,241,658 $84.47m OTCQB
InMed Pharmaceuticals Inc IMLFF 0.657 13.42 % 2,678,367 $71.15m OTCQB
Tetra Bio Pharma Inc TBP:CNX 0.690 1.47 % 729,880 $68.54m CSE
Tetra Bio-Pharma Inc GRPOF 0.513 0.51 % 125,154 $50.92m OTCQB
Kalytera Therapeutics Inc KALY:CA 0.400 1.27 % 864,373 $50.29m TSXVAbattis Bioceuticals Corp ATT:CNX 0.340 19.30 % 6,129,756 $45.46m CSE
GB Sciences Inc GBLX 0.325 3.83 % 743,282 $36.04m OTCQB
Vitality Biopharma VBIO 2.000 2.77 % 121,450 $35.57m OTCQB
Abattis Bioceuticals Ord ATTBF 0.250 19.05 % 4,859,493 $33.42m OTCQB
Omni Health Inc OMHE 0.022 -4.31 % 67,436 $21.66m OTCPK
Easton Pharms Inc EAPH 0.031 15.93 % 5,357,644 $18.16m OTCPK
India Globalization Capital Inc. IGC 0.540 7.12 % 426,334 $13.92m NYSE MKT
Veritas Pharma Inc VRT:CNX 0.520 4.00 % 205,060 $12.91m CSE
CannaPharmaRx Inc CPMD 0.600 0.00 % 50 $10.78m OTCPK
Veritas Pharma Inc VRTHF 0.389 4.91 % 26,700 $9.65m OTCPK
Nemus Bioscience Inc. NMUS 0.315 5.00 % 181,762 $8.10m OTCQB
Therapix Biosciences Ltd. TRPX 7.850 5.51 % 93,740 $6.95m NCM
Generex Biotechnology GNBT 4.500 -4.26 % 1,710 $6.12m OTCPK
Premier Biomedical Inc BIEI 0.017 2.99 % 1,798,000 $3.90m OTCQB
Plandai Biotechnology Inc PLPL 0.015 -14.29 % 996,153 $2.80m OTCPK
ViaDerma Inc VDRM 0.025 1.64 % 6,224,086 $1.86m OTCPK
Verde Science Inc VRCI 0.009 -14.14 % 168,732 $202.88k OTCPK


http://business.financialpost.com/news/agriculture/trudeaus-new-pot-law-is-expected-to-boost-marijuana-industry-mergers-as-details-left-to-provinces

Legalization will be announced this Thursday, April 13, 2017 in Canada!

Lets have look at the PR again...
The Cannabis Provisional Patent #62466209, a patent for delivering medical marijuana /cannabis to the body by applying the medication onto the skin in an ointment base topical solution. The second provisional patent #62433964 for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinarian uses. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2017.

The Company has signed a LOI or letter of intent to work with a Canadian-based investment group with expertise in logistics that includes distribution for the new and anticipated products. The investment group will target sales for the new patent pending products to countries that have accepted "Medical Marijuana" and "Recreational Use" of cannabis products and technologies for delivery of CBD and THC. This group will also target countries that allow the "Clinical Studies" for medical testing such as the United Kingdom and other Asian countries.

http://www.marketwired.com/press-release/viaderma-receives-provisional-patent-numbers-its-fda-registered-viabecline-cannabis-otc-pink-vdrm-2203945.htm


This alone will send us over 50 cents, let alone the FDA approval coming in 6 weeks, updates from the DFCon, 500,000 units at $125/ in sales coming this year, among all the other things in the pipeline!


Long $VDRM